Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Index
RUT
Market Cap
431.53M
Enterprise Value
993.37M
Income
17.93M
Sales
124.78M
Book/sh
14.46
Cash/sh
0.09
Employees
35
IPO
May 21, 2015
P/E
22.65
Forward P/E
30.73
PEG
0.31
P/S
3.46
P/B
1.04
P/C
161.62
P/FCF
11.14
EV/EBITDA
12.24
EV/Sales
7.96
Quick Ratio
2.24
Current Ratio
2.24
Debt/Eq
1.36
LT Debt/Eq
1.36
Option/Short
Yes / Yes
EPS (ttm)
0.66
EPS next Y
0.49
EPS next Q
0.09
EPS this Y
350.00%
EPS next Y
36.11%
EPS next 5Y
98.95%
EPS past 3/5Y
-54.31% -37.30%
Sales past 3/5Y
7.46% 9.87%
EPS Y/Y TTM
271.76%
Sales Y/Y TTM
5.66%
EPS Q/Q
111.75%
Sales Q/Q
7.35%
Insider Own
6.61%
Insider Trans
0.96%
Inst Own
82.65%
Inst Trans
0.56%
ROA
1.82%
ROE
4.21%
ROIC
1.83%
Gross Margin
46.07%
Oper. Margin
30.50%
Profit Margin
14.37%
SMA20
-2.02%
SMA50
-11.99%
SMA200
-10.27%
Trades
Shs Outstand
28.66M
Shs Float
26.76M
52W High
19.17 -21.42%
52W Low
13.23 13.83%
Volatility
2.14% 2.98%
ATR (14)
0.42
RSI (14)
34.58
Beta
0.65
Rel Volume
0.67
Avg Volume
257.30K
Volume
14,157
Perf Week
1.28%
Perf Month
-18.86%
Perf Quarter
-12.54%
Perf Half Y
-11.88%
Perf YTD
-8.28%
Perf Year
-0.99%
Perf 3Y
-54.18%
Perf 5Y
-68.82%
Perf 10Y
-32.16%
Prev Close
15.09
Price
15.06
Change %
-0.20%
Date Action Analyst Rating Change Price Target Change
Jul-17-26Initiated Huntington Outperform $20
Sep-16-24Upgrade Evercore ISI Underperform → In-line $21 → $18
May-01-24Downgrade Piper Sandler Overweight → Neutral $36 → $26
Nov-02-23Downgrade Evercore ISI Outperform → In-line $36 → $32
Sep-22-23Downgrade Robert W. Baird Outperform → Neutral $43 → $33
Jan-13-23Upgrade Janney Neutral → Buy $44
Nov-25-20Upgrade Evercore ISI In-line → Outperform
Nov-05-20Reiterated B. Riley Securities Neutral $47 → $49
Sep-30-20Resumed Robert W. Baird Outperform $51
Sep-09-20Initiated Colliers Securities Buy $52
Aug-05-26 05:07PM
08:30AM
Aug-04-26 04:38PM
04:15PM
Jul-17-26 05:30PM
04:45PM Loading…
Jun-24-26 04:45PM
May-06-26 08:30AM
May-05-26 04:55PM
04:15PM
Apr-30-26 06:38PM
Apr-13-26 05:30PM
Feb-23-26 09:40AM
Feb-18-26 04:05PM
11:55AM
08:30AM
06:30PM Loading…
Feb-17-26 06:30PM
05:45PM
04:54PM
04:30PM
Feb-12-26 06:02PM
Feb-11-26 10:45AM
09:21AM
Feb-02-26 05:35PM
Jan-27-26 06:55PM
Jan-21-26 09:35AM
Jan-19-26 09:27AM
Dec-03-25 05:27PM
Nov-06-25 08:01AM
Oct-30-25 03:51PM
Oct-28-25 06:30PM
05:45PM Loading…
05:45PM
04:45PM
04:15PM
09:57AM
Oct-27-25 09:41AM
Oct-23-25 06:05PM
Oct-03-25 04:30PM
09:50AM
Jul-31-25 03:24AM
Jul-29-25 06:30PM
05:40PM
04:30PM
09:57AM
Jul-28-25 09:36AM
Jul-24-25 04:30PM
Jul-01-25 05:40PM
Jun-11-25 06:09PM
Jun-04-25 10:31AM
May-06-25 04:30PM
07:21AM
May-03-25 09:54AM
01:26AM
May-01-25 03:14AM
Apr-30-25 01:56PM
Apr-29-25 07:00PM
05:45PM
04:43PM
04:30PM
Apr-24-25 05:44PM
Apr-11-25 10:01PM
Apr-10-25 10:27AM
Apr-07-25 07:30AM
Apr-02-25 06:00PM
Feb-20-25 02:09AM
12:33AM
Feb-19-25 04:54AM
Feb-18-25 06:30PM
05:50PM
05:00PM
04:30PM
02:50AM
Feb-13-25 05:42PM
Jan-16-25 05:15PM
Dec-18-24 09:40AM
Dec-13-24 08:30PM
Dec-02-24 02:21PM
Nov-15-24 09:40AM
Oct-31-24 04:08AM
04:06AM
03:13AM
Oct-29-24 06:30PM
05:45PM
04:43PM
04:30PM
09:15AM
09:00AM
Oct-28-24 09:07AM
Oct-24-24 06:00PM
Oct-20-24 02:39PM
Oct-17-24 03:08PM
Oct-16-24 04:30PM
Oct-09-24 03:34PM
05:29AM
Oct-04-24 06:15AM
Oct-01-24 06:19PM
Sep-11-24 01:17PM
Sep-06-24 06:43PM
Aug-06-24 11:30PM
Aug-05-24 03:00PM
Jul-30-24 07:00PM
Community Healthcare Trust, Inc. is a healthcare real estate company, which engages in acquiring real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. The company was founded by Timothy G. Wallace, William Page Barnes, Leigh Ann Stach, Ron Hart, Bill Davis, Stephen M. Harrison, Mike Willman, and Jim Short on March 28, 2014 and is headquartered in Franklin, TN.
CEOMr. David H. Dupuy
Executive VPMr. William G. Monroe IV
Executive VP & Chief Accounting OfficerMs. Leigh Ann Stach
Senior Vice President of Asset ManagementMr. Mark E. Kearns
VP & ControllerGary Moothart
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dupuy David H.CEO and PresidentAug 14 '26Buy15.1310,000151,300557,262Aug 17 04:15 PM
Hensley Robert ZDirectorAug 11 '26Buy15.218,000121,680103,702Aug 12 04:15 PM
Cotman CathrineDirectorNov 04 '25Buy14.664,00058,64037,635Nov 05 04:15 PM
HROW Harrow Inc daily Stock Chart
Index
RUT
Market Cap
1.42B
Enterprise Value
1.64B
Income
-37.23M
Sales
275.59M
Book/sh
0.41
Cash/sh
2.24
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
373
IPO
Apr 24, 2007
P/E
-
Forward P/E
16.86
PEG
-
P/S
5.16
P/B
93.57
P/C
16.96
P/FCF
283.36
EV/EBITDA
60.81
EV/Sales
5.95
Quick Ratio
2.08
Current Ratio
2.24
Debt/Eq
19.79
LT Debt/Eq
19.72
Option/Short
Yes / Yes
EPS (ttm)
-1.00
EPS next Y
2.25
EPS next Q
0.19
EPS this Y
33.93%
EPS next Y
2532.43%
EPS next 5Y
-
EPS past 3/5Y
35.17% -1.53%
Sales past 3/5Y
45.39% 40.99%
EPS Y/Y TTM
-244.96%
Sales Y/Y TTM
21.05%
EPS Q/Q
-459.56%
Sales Q/Q
10.85%
Insider Own
15.30%
Insider Trans
-3.36%
Inst Own
57.70%
Inst Trans
-0.42%
ROA
-9.77%
ROE
-114.80%
ROIC
-11.82%
Gross Margin
73.28%
Oper. Margin
2.07%
Profit Margin
-13.51%
SMA20
-4.86%
SMA50
-8.13%
SMA200
-8.19%
Trades
Shs Outstand
37.48M
Shs Float
31.75M
52W High
54.85 -30.82%
52W Low
28.54 32.95%
Volatility
5.01% 4.88%
ATR (14)
2.00
RSI (14)
41.47
Beta
0.24
Rel Volume
0.28
Avg Volume
665.61K
Volume
15,254
Perf Week
-7.34%
Perf Month
-2.56%
Perf Quarter
7.77%
Perf Half Y
-29.97%
Perf YTD
-22.56%
Perf Year
-2.68%
Perf 3Y
140.00%
Perf 5Y
302.38%
Perf 10Y
893.31%
Prev Close
38.54
Price
37.94
Change %
-1.55%
Date Action Analyst Rating Change Price Target Change
Jul-11-25Initiated Cantor Fitzgerald Overweight $76
Jun-12-25Initiated BTIG Research Buy $62
Jun-10-25Initiated William Blair Outperform
Feb-06-25Initiated H.C. Wainwright Buy $57
Dec-04-24Reiterated B. Riley Securities Buy $73 → $69
Apr-11-24Initiated Craig Hallum Buy $24
Sep-08-22Resumed B. Riley Securities Buy $17
Oct-14-21Resumed B. Riley Securities Buy $16
Sep-24-21Initiated Aegis Capital Buy $15
Jul-02-21Initiated Ladenburg Thalmann Buy $14.25
Aug-20-26 07:00AM
Aug-11-26 03:01PM
08:30AM
Aug-10-26 05:50PM
04:05PM
07:00AM Loading…
Aug-06-26 07:00AM
Jul-27-26 07:00AM
Jul-20-26 08:00AM
07:00AM
Jul-01-26 07:00AM
07:00AM
Jun-10-26 07:00AM
May-27-26 07:00AM
May-12-26 03:01PM
08:30AM
04:37PM Loading…
May-11-26 04:37PM
04:05PM
Apr-27-26 07:00AM
Apr-16-26 07:00AM
Apr-14-26 10:30AM
Mar-24-26 04:57PM
08:15AM
Mar-18-26 07:00AM
Mar-09-26 09:03PM
Mar-04-26 07:00AM
Mar-03-26 04:14PM
11:18AM
08:11AM
07:00AM
Mar-02-26 06:00PM
05:08PM Loading…
05:08PM
04:05PM
Feb-28-26 09:32AM
Feb-27-26 12:58PM
Feb-26-26 05:35AM
Feb-24-26 10:00AM
08:00AM
Feb-23-26 02:20PM
10:00AM
Feb-18-26 07:00AM
Feb-17-26 06:01PM
07:00AM
Feb-04-26 01:07PM
Feb-03-26 06:28AM
Feb-02-26 07:00AM
Jan-15-26 01:00PM
08:55AM
Dec-09-25 12:56PM
Nov-24-25 07:00AM
Nov-18-25 07:00AM
Nov-14-25 05:03PM
Nov-11-25 02:01PM
Nov-10-25 04:31PM
04:05PM
Oct-27-25 07:00AM
Oct-08-25 11:23AM
Oct-06-25 07:00AM
Sep-26-25 08:57AM
07:00AM
Sep-25-25 04:05PM
Sep-15-25 07:00AM
Sep-08-25 05:57PM
08:00AM
Sep-02-25 04:07AM
Aug-26-25 04:15AM
Aug-15-25 12:20PM
10:00AM
09:55AM
Aug-14-25 02:36PM
Aug-11-25 05:55PM
04:01PM
09:23AM
Aug-08-25 09:22AM
Aug-06-25 07:00AM
Aug-04-25 10:00AM
Jul-29-25 07:00AM
Jul-21-25 03:34PM
Jul-17-25 07:00AM
07:00AM
Jul-14-25 10:01AM
Jul-12-25 09:40AM
Jul-11-25 09:38AM
Jul-06-25 04:15AM
Jul-02-25 09:00AM
Jun-18-25 07:00AM
Jun-09-25 07:00AM
May-14-25 10:07AM
07:00AM
May-10-25 03:03AM
May-08-25 05:10PM
04:01PM
09:32AM
May-07-25 10:28AM
May-05-25 07:00AM
Apr-30-25 07:35AM
Apr-29-25 07:35AM
Apr-24-25 10:00AM
Apr-21-25 04:26PM
Apr-10-25 07:00AM
Mar-29-25 04:30PM
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company's FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company's ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
CEOMr. Mark L. Baum J.D.
C.M.A.Mr. Andrew R. Boll C.F.A.
Pharm.D.Dr. Amir W. Shojaei Ph.D.
President & CEO of Harrow's ImprimisRx DivisionMr. Francis W. Mullery
Chief Accounting OfficerMr. Randall E. Pollard
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AMIR SHOJAEICHIEF SCIENTIFIC OFFICERAug 14 '26Proposed Sale40.0011,250450,000Aug 21 06:32 PM
Shojaei AmirCHIEF SCIENTIFIC OFFICERAug 14 '26Option Exercise35.9611,250404,55011,250Aug 17 05:47 PM
Shojaei AmirCHIEF SCIENTIFIC OFFICERAug 14 '26Sale40.0011,250450,0000Aug 17 05:47 PM
Graves Adrienne LDirectorMay 18 '26Buy31.071,00031,0701,000May 19 07:00 AM
SILVERNAIL LAUREN PDirectorMay 18 '26Buy31.001,00031,0001,000May 19 07:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERMay 14 '26Buy30.2010,000302,0002,996,130May 15 07:01 AM
BOLL ANDREW R.PRESIDENT AND CFOMay 14 '26Buy29.903,500104,650814,679May 15 07:00 AM
Opaleye Management Inc.10% OwnerMar 04 '26Sale39.67138,2635,485,18459,428Mar 05 04:05 PM
Opaleye Management Inc.10% OwnerMar 03 '26Sale39.1560,3092,361,24263,691Mar 05 04:05 PM
Opaleye Management Inc.10% OwnerFeb 27 '26Sale54.185,000270,90065,000Mar 03 04:05 PM
Opaleye Management Inc.10% OwnerJan 06 '26Sale53.3520,0001,066,91470,000Jan 08 04:05 PM
BOLL ANDREW R.PRESIDENT AND CFODec 12 '25Option Exercise3.9560,000237,000837,844Dec 16 08:50 PM
BAUM MARK LCHIEF EXECUTIVE OFFICERDec 12 '25Option Exercise3.95180,000711,0003,066,124Dec 16 08:48 PM